These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8111061)

  • 1. Treatment approaches to the low-grade lymphomas.
    Horning SJ
    Blood; 1994 Feb; 83(4):881-4. PubMed ID: 8111061
    [No Abstract]   [Full Text] [Related]  

  • 2. bcl-1, t(11;14), and mantle cell-derived lymphomas.
    Raffeld M; Jaffe ES
    Blood; 1991 Jul; 78(2):259-63. PubMed ID: 2070063
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction.
    Gribben JG; Nadler LM
    Important Adv Oncol; 1994; ():117-29. PubMed ID: 8206485
    [No Abstract]   [Full Text] [Related]  

  • 4. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
    Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
    Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.
    Mitani S; Aoki N; Mizutani S; Fujiwara M; Kitagawa T; Uehara T; Mori S
    Jpn J Cancer Res; 1993 Jan; 84(1):37-41. PubMed ID: 8449825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): a molecular and immunohistochemical study.
    Lambrechts AC; Looijenga LH; van't Veer MB; van Echten J; Timens W; Oosterhuis JW
    Br J Cancer; 1995 Jan; 71(1):73-7. PubMed ID: 7819053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL).
    Zucca E; Stein H; Coiffier B
    Ann Oncol; 1994 Jul; 5(6):507-11. PubMed ID: 7918122
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations of the BCL-6 gene in diffuse large-cell lymphoma.
    Ye BH; Lo Coco F; Chang CC; Zhang J; Migliazza A; Cechova K; Knowles DM; Offit K; Chaganti RS; Dalla-Favera R
    Curr Top Microbiol Immunol; 1995; 194():101-8. PubMed ID: 7895484
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
    Barker RL; Worth CA; Peiper SC
    Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT; Innes DJ; Williams ME
    J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
    Chleq-Deschamps CM; LeBrun DP; Huie P; Besnier DP; Warnke RA; Sibley RK; Cleary ML
    Blood; 1993 Jan; 81(2):293-8. PubMed ID: 8422456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic and molecular aspects in MALT lymphomas].
    Robledo M; Santos M; Santón A; Echezarreta G; Rivas C; Benítez J
    Sangre (Barc); 1991 Aug; 36(4):295-9. PubMed ID: 1776108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas.
    Klefstrom J; Franssila K; Peltomäki P; Kaartinen M; Solin ML; Knuutila S
    Leuk Res; 1994 Apr; 18(4):245-50. PubMed ID: 8170168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bcl-2 gene and protein in malignant lymphomas.
    Cleary ML
    Bull Cancer; 1991; 78(2):187-93. PubMed ID: 1903662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
    Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
    Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction monitoring for bcl-2 can be a dependable test under the right conditions.
    Cabanillas F; Lee MS
    J Clin Oncol; 1995 Mar; 13(3):795-6. PubMed ID: 7884438
    [No Abstract]   [Full Text] [Related]  

  • 20. t(11;18)(q21;q21.1): a recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)?
    Horsman D; Gascoyne R; Klasa R; Coupland R
    Genes Chromosomes Cancer; 1992 Mar; 4(2):183-7. PubMed ID: 1373320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.